People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

People in Phoenix suffering from severe depression now have a Ketamine-derived nasal spray available for treatment.

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...